Mutares Hires JPMorgan to Map an Efacec Exit Between a Trade Sale and a Euronext Lisbon IPO

German turnaround fund Mutares has appointed JPMorgan Chase to advise on the next chapter of its Portuguese engineering portfolio company Efacec, with the bank running parallel options work on a trade sale and a Euronext Lisbon initial public offering, ECO reported on Tuesday citing Bloomberg. The mandate marks the first concrete signal that Mutares is preparing to monetise its 2023 acquisition of the Matosinhos-headquartered group, and it positions Euronext Lisbon for what would be its first new listing since Greenvolt's 2021 debut — a four-and-a-half-year drought that has thinned the PSI index to just 16 constituents, among the smallest blue-chip benches in Western Europe.

Efacec carries roughly 1,660 employees and an order book of about €700 million, with management guiding EBITDA between €40 million and €50 million for 2026. Cantor Fitzgerald analysts pencil enterprise-value range of €300 million to €420 million on the current financial trajectory, with the EBITDA margin tracking near 14% and on a guided path toward 20% by 2027 as the legacy turnaround work runs its course. Order intake in 2025 cleared €450 million, comfortably above the 2024 baseline. JPMorgan, Mutares and Efacec all declined to comment when contacted by Bloomberg.

The exit framework is constrained by the Article 13 vendor lock-up that Portugal's state holding agency Parpública negotiated when it sold Efacec to Mutares in 2023 for a token consideration after the failed Têxtil Manuel Gonçalves-led recapitalisation. Until 2026, Mutares could not alienate the asset without Council of Ministers consent; from 2026 onward, any sale, IPO or merger has to be executed through a competitive process. The Tribunal de Contas (Court of Auditors) flagged the carve-out at the time as a critical control on the state's residual exposure, given that the public purse injected roughly €165 million into Efacec across the 2020-2023 nationalisation-and-divestment period.

For Mutares's Munich-based partners, an Efacec exit would crystallise one of the fund's larger industrial bets, with the group's own equity narrative pointing to Efacec as a potential star realisation in the 2026 vintage. The Lisbon IPO route carries the symbolic upside of restoring listing flow to the Bolsa de Lisboa, where bourse chief Isabel Ucha has spent the last 18 months courting issuers in renewables, mobility and industrial transformation. The trade-sale route is structurally cleaner for Mutares but exposes Efacec to consolidation bids from larger European peers including Schneider Electric (France), Hitachi Energy (Switzerland) or domestic strategics including Sonae Capital.

The timing aligns with the Article 6 Lei das Privatizações sequencing that government rolled out in May for TAP and is preparing for Águas de Portugal, signalling that the state is comfortable releasing the Efacec consent. The Conselho de Concorrência (Competition Authority) would clear an industrial-buyer transaction under the standard EU Merger Regulation thresholds, while a Lisbon IPO would land within the Comissão do Mercado de Valores Mobiliários (CMVM) listing-prospectus rulebook — a regime that has recently been simplified to lower the cost of issuance for mid-cap industrials. For PSI watchers, the prospect of a fresh listing is the more interesting story; for Mutares, the question is which option clears the higher multiple after JPMorgan's auction process.